ClinicalTrials.gg
Sign In

End Stage Liver Disease clinical trials

The registry lists 155 studies for End Stage Liver Disease across more than 10 countries. 31 are recruiting or about to start. 104 of them are mainly about End Stage Liver Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the End Stage Liver Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
68
Status unknown
26
Recruiting
21
Terminated
13
Active, not recruiting
10
Not yet recruiting
7

Phase

Phase 2
17
Phase 1
16
Phase 4
8
Phase 3
8
Early Phase 1
3

Where

United States
66
China
15
Canada
12
United Kingdom
9
Spain
7
India
7

Who runs them

Mayo Clinic (5) · RenJi Hospital (4) · Centre hospitalier de l'Université de Montréal (CHUM) (4) · Massachusetts General Hospital (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4) · University of California, Los Angeles (3) · University of California, San Francisco (3) · Tongji Hospital (3)

What is being tested here

Drugs under test in End Stage Liver Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tranexamic Acid101
Siplizumab101
Custodiol-N solution111
Mycophenolic Acid002
Angiotensin II001
Tocotrienols001
Growth Hormone011
Escherichia coli strain nissle 1917001
Glutathione011
Fatty Acids, Unsaturated001

Coming up

1phase 3 study under way
13studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 21 End Stage Liver Disease studies recruiting now, 14 (67%) set no upper age limit and 6 (29%) stop at 75 or younger. 1 (5%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (5%) take healthy volunteers.

Recruiting studies that take each age, of 21
AgeWomenMen
101 (5%)1 (5%)
1820 (95%)20 (95%)
3020 (95%)20 (95%)
4020 (95%)20 (95%)
5020 (95%)20 (95%)
6520 (95%)20 (95%)
7517 (81%)17 (81%)
8514 (67%)14 (67%)

Across all 155 studies, recruiting or not: 32% stop at 75 or younger and 13% at 65; 11% take children; 0% are for women only and 1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long End Stage Liver Disease studies take

Of 36 interventional studies with no phase under End Stage Liver Disease, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase28 mo21–72 · 36 studies—33 mo21–72 · 35 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 155. Browse all 155 → or search them.